samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PharmaLinkFHI Changes Their Name to Novella Clinical

Novella Clinical

Three Experienced Companies – Combined For One Goal

PharmaLinkFHI announced today they have officially changed their name to Novella Clinical. Global growth through the 2008 acquisition of Matrix Clinical in the U.K. made the name change necessary.

The announcement was made simultaneously at their global headquarters in ResearchTrianglePark, as well as at their European office in Stevenage UK and at the Drug Information Association’s (DIA) annual conference – one of the most significant events in the industry.

“The combination of PharmaLink and Matrix was an important event in the history of the company. It has allowed us to support our biopharmaceutical and medical device clients globally in their efforts to bring promising products to market. Our focus on leveraging clinical and therapeutic expertise with industry leading eClinical processes and technologies allows us to manage our business more effectively and provide superior clinical trial execution for our sponsors, now on a global scale” said Richard Staub, President and Chief Executive Officer.

Nigel Trim, Managing Director, European Operations, added, “As Novella Clinical we are poised to continue our growth globally – both within our current geographic footprint as well as expanding into new regions of the world. We are excited to reintroduce ourselves to the market as Novella Clinical.”

Novella provides their clients with full-service CRO support through its biopharmaceutical and medical device divisions.  Both divisions are built from teams of therapeutically trained professionals using industry-leading eClinical processes. For clients who don’t require full-service CRO support, Novella Clinical Resourcing (formerly known as eReady Monitors and Matrix Clinical Solutions) offers flexible staffing solutions to supplement their clinical teams with unparalleled expertise.

In addition to the new name and rebranding efforts, Novella Clinical is rolling out a new line of communications to further differentiate themselves in the CRO marketplace. The communications are based on the company’s brand promise of helping their clients achieve their goal of positively improving people’s lives. That promise is further exemplified in their new tagline, “Moving Potential. Forward.”

+1 919 484 1921
www.novellaclinical.com
4309 Emperor Boulevard, Suite 400, Durham, NC USA 27703
 
Print this page
Send to a friend
   
spacer

News and Press Releases

ClinTec International

ClinTec International, a global Clinical Research Organisation (“CRO”) announces a financial and strategic partnership with Elephant Capital Plc., an AIM market listed private equity firm. With an investment of £8 Million GBP, Elephant has acquired a significant minority stake in ClinTec. Through this investment, Elephant has entered the attractive clinical research base, where ClinTec operates as a global provider of outsourcing solutions addressing the drug development lifecycle. Managing Partner of Elephant Capital LLP, Gaurav Burman, and Non-Executive Director of Elephant Capital Plc, James Hauslein, have also made personal co-investments in this transaction.
More info >>

Industry Events

Biotech Outsourcing Strategies Clinical 2010

21 September 2010, Royal College of Physicians, London, UK

Following the successful launch in 2009, Bio2Business is pleased to host Biotech Outsourcing Strategies clinical 2010 which will take place at the Royal College of Physicians in London and will run alongside our BOS non clinical event.
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement